Ionis Pharmaceuticals, Inc. (IONS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:51AM EST. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.88B |
| Enterprise Value | 3.20B |
| Trailing P/E | 114.71 |
| Forward P/E | 90.91 |
| PEG Ratio (5 yr expected) | 25.70 |
| Price/Sales (ttm) | 5.85 |
| Price/Book (mrq) | 7.31 |
| Enterprise Value/Revenue | 4.84 |
| Enterprise Value/EBITDA | -13.32 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.99 |
| 52-Week Change 3 | -48.95% |
| S&P500 52-Week Change 3 | 23.73% |
| 52 Week High 3 | 64.37 |
| 52 Week Low 3 | 25.04 |
| 50-Day Moving Average 3 | 32.24 |
| 200-Day Moving Average 3 | 38.86 |
Share Statistics
| Avg Vol (3 month) 3 | 1.04M |
| Avg Vol (10 day) 3 | 1.33M |
| Shares Outstanding 5 | 141.21M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 140M |
| % Held by Insiders 1 | 0.81% |
| % Held by Institutions 1 | 86.94% |
| Shares Short (Nov. 14, 2021) 4 | 6.19M |
| Short Ratio (Nov. 14, 2021) 4 | 5.63 |
| Short % of Float (Nov. 14, 2021) 4 | 5.19% |
| Short % of Shares Outstanding (Nov. 14, 2021) 4 | 4.38% |
| Shares Short (prior month Oct. 14, 2021) 4 | 6.78M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | -93.04% |
| Operating Margin (ttm) | -33.19% |
Management Effectiveness
| Return on Assets (ttm) | -4.98% |
| Return on Equity (ttm) | -57.64% |
Income Statement
| Revenue (ttm) | 660.73M |
| Revenue Per Share (ttm) | 4.70 |
| Quarterly Revenue Growth (yoy) | -16.90% |
| Gross Profit (ttm) | 182.24M |
| EBITDA | -201.71M |
| Net Income Avi to Common (ttm) | -614.97M |
| Diluted EPS (ttm) | -4.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2B |
| Total Cash Per Share (mrq) | 14.16 |
| Total Debt (mrq) | 1.31B |
| Total Debt/Equity (mrq) | 246.85 |
| Current Ratio (mrq) | 7.70 |
| Book Value Per Share (mrq) | 3.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74.91M |
| Levered Free Cash Flow (ttm) | 86.96M |
